In light of its crucial role in regulating blood glucose levels, α-amylase inhibition has emerged as a promising strategy for managing diabetes mellitus (DM), particularly type II DM, which is marked by impaired glucose metabolism and insulin resistance [10,11]. The gene discussed is INS; the disease is diabetes mellitus.